uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Prediction of individual genetic risk to prostate cancer using a polygenic score.
Show others and affiliations
2015 (English)In: The Prostate, ISSN 0270-4137, E-ISSN 1097-0045, Vol. 75, no 13, p. 1467-74Article in journal (Refereed) Published
Abstract [en]

BACKGROUND: Polygenic risk scores comprising established susceptibility variants have shown to be informative classifiers for several complex diseases including prostate cancer. For prostate cancer it is unknown if inclusion of genetic markers that have so far not been associated with prostate cancer risk at a genome-wide significant level will improve disease prediction.

METHODS: We built polygenic risk scores in a large training set comprising over 25,000 individuals. Initially 65 established prostate cancer susceptibility variants were selected. After LD pruning additional variants were prioritized based on their association with prostate cancer. Six-fold cross validation was performed to assess genetic risk scores and optimize the number of additional variants to be included. The final model was evaluated in an independent study population including 1,370 cases and 1,239 controls.

RESULTS: The polygenic risk score with 65 established susceptibility variants provided an area under the curve (AUC) of 0.67. Adding an additional 68 novel variants significantly increased the AUC to 0.68 (P = 0.0012) and the net reclassification index with 0.21 (P = 8.5E-08). All novel variants were located in genomic regions established as associated with prostate cancer risk.

CONCLUSIONS: Inclusion of additional genetic variants from established prostate cancer susceptibility regions improves disease prediction.

Place, publisher, year, edition, pages
2015. Vol. 75, no 13, p. 1467-74
Keywords [en]
polygenic risk score, prostate cancer, risk prediction
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-349374DOI: 10.1002/pros.23037PubMedID: 26177737OAI: oai:DiVA.org:uu-349374DiVA, id: diva2:1201587
Note

Pär Stattin, Institutionen för kirurgiska vetenskaper, urologi, Uppsala universitet är en av medarbetarna, collaborators. 

Available from: 2018-04-26 Created: 2018-04-26 Last updated: 2018-04-26

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed
In the same journal
The Prostate
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf